Pharmacological effects of rutaecarpine as a cardiovascular protective agent

Molecules

Volumn 15, Issue 3, 2010, Pages 1873-1881

  Jia, Sujie ^a   Hu, Changping ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b NONE

Author keywords

Anti inflammation; Anti platelet aggregation; Cardiac protection; Rutaecarpine; Vasodilator

Indexed keywords

CARDIOTONIC AGENT; INDOLE ALKALOID; QUINAZOLINE DERIVATIVE; RUTAECARPINE;

ANIMAL; ARTICLE; HUMAN;

ANIMALS; CARDIOTONIC AGENTS; HUMANS; INDOLE ALKALOIDS; QUINAZOLINES;

EID: 77950361420     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15031873     Document Type: Article

References (45)

1. Lee, S. H.; Son, J. K.; Jeong, B. S.; Jeong, T. C.; Chang, H. W.; Lee, E. S.; Jahng, Y. Progress in the studies on rutaecarpine. Molecules 2008, 13, 272-300.
2. Wang, L.; Hu, C. P.; Deng, P. Y.; Shen, S. S.; Zhu, H. Q.; Ding, J. S.; Tan, G. S.; Li, Y. J. The protective effects of rutaecarpine on gastric mucosa injury in rats. Planta Med. 2005, 71, 416-419.
3. Liao, J. F.; Chen, C. F.; Chow, S. Y. [Pharmacological studies of Chinese herbs. (9) Pharmacological effects of Evodiae fructus (author's transl)]. Taiwan Yi Xue Hui Za Zhi 1981, 80, 30-38.
4. Wang, G. J.; Shan, J.; Pang, P. K.; Yang M. C.; Chou, C. J.; Chen, C. F. The vasorelaxing action of rutaecarpine: Direct paradoxical effects on intracellular calcium concentration of vascular smooth muscle and endothelial cells. J. Pharmacol. Exp. Ther. 1996, 276, 1016-1021.
5. Sheu, J. R.; Hung, W. C.; Wu, C. H.; Lee, Y. M.; Yen, M. H. Antithrombotic effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, on platelet plug formation in in vivo experiments. Br. J. Haematol. 2000, 110, 110-115.
6. Kobayashi, Y.; Hoshikuma, K.; Nakano, Y.; Yokoo, Y.; Kamiya, T. The positive inotropic and chronotropic effects of evodiamine and rutaecarpine, indoloquinazoline alkaloids isolated from the fruits of Evodia rutaecarpa, on the guinea-pig isolated right atria: Possible involvement of vanilloid receptors. Planta Med. 2001, 67, 244-248.
7. Moon, T. C.; Murakami, M.; Kudo, I.; Son, K. H.; Kim, H. P.; Kang, S. S.; Chang, H. W. A new class of COX-2 inhibitor, rutaecarpine from Evodia rutaecarpa. Inflamm. Res. 1999, 48, 621-625.
8. Hu, C. P.; Xiao, L.; Deng, H. W.; Li, Y. J. The cardioprotection of rutaecarpine is mediated by endogenous calcitonin related-gene peptide through activation of vanilloid receptors in guinea-pig hearts. Planta Med. 2002, 68, 705-709.
9. Yi, H. H.; Rang, W. Q.; Deng, P. Y.; Hu, C. P.; Liu, G. Z.; Tan, G. S.; Xu, K. P.; Li, Y. J. Protective effects of rutaecarpine in cardiac anaphylactic injury is mediated by CGRP. Planta Med. 2004, 70, 1135-1139.
10. Hu, C. P.; Li, N. S.; Xiao, L.; Deng, H. W.; Li, Y. J. Involvement of capsaicin-sensitive sensory nerves in cardioprotection of rutaecarpine in rats. Regul. Pept. 2003, 114, 45-49.
11. Zvara, A.; Bencsik, P.; Fodor, G.; Csont, T.; Hackler, L., Jr.; Dux, M.; Furst, S.; Jancso, G.; Puskas, L. G.; Ferdinandy, P. Capsaicin-sensitive sensory neurons regulate myocardial function and gene expression pattern of rat hearts: A DNA microarray study. FASEB J. 2006, 20, 160-162.
12. Huang, W.; Rubinstein, J.; Prieto, A. R.; Thang, L. V.; Wang, D. H. Transient receptor potential vanilloid gene deletion exacerbates inflammation and atypical cardiac remodeling after myocardial infarction. Hypertension 2009, 53, 243-250.
13. Chiou, W. F.; Liao, J. F.; Chen, C. F. Comparative study of the vasodilatory effects of three quinazoline alkaloids isolated from Evodia rutaecarpa. J. Nat. Prod. 1996, 59, 374-378.
14. Chiou, W. F.; Shum, A. Y.; Liao, J. F.; Chen, C. F. Studies of the cellular mechanisms underlying the vasorelaxant effects of rutaecarpine, a bioactive component extracted from an herbal drug. J. Cardiovasc. Pharmacol. 1997, 29, 490-498.
15. Wang, G. J.; Wu, X. C.; Chen, C. F.; Lin, L. C.; Huang, Y. T.; Shan, J.; Pang, P. K. Vasorelaxing action of rutaecarpine: Effects of rutaecarpine on calcium channel activities in vascular endothelial and smooth muscle cells. J. Pharmacol. Exp. Ther. 1999, 289, 1237-1244.
16. Chiou, W. F.; Chou, C. J.; Liao, J. F.; Sham, A. Y.; Chen, C. F. The mechanism of the vasodilator effect of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa. Eur. J. Pharmacol. 1994, 257, 59-66.
17. Hu, C. P.; Xiao, L.; Deng, H. W.; Li, Y. J. The depressor and vasodilator effects of rutaecarpine are mediated by calcitonin gene-related peptide. Planta Med. 2003, 69, 125-129.
18. Deng, P. Y.; Ye, F.; Cai, W. J.; Deng, H. W.; Li, Y. J. Role of calcitonin gene-related peptide in the phenol-induced neurogenic hypertension in rats. Regul. Pept. 2004, 119, 155-161.
19. Yu, J.; Tan, G. S.; Deng, P. Y.; Xu, K. P.; Hu, C. P.; Li, Y. J. Involvement of CGRP in the inhibitory effect of rutaecarpine on vasoconstriction induced by anaphylaxis in guinea pig. Regul. Pep. 2005, 125, 93-97.
20. Deng, P. Y.; Ye, F.; Cai, W. J.; Tan, G. S.; Hu, C. P.; Deng, H. W.; Li, Y. J. Stimulation of calcitonin gene-related peptide synthesis and release: Mechanisms for a novel antihypertensive drug, rutaecarpine. J. Hypertens 2004, 22, 1819-1829.
21. Qin, X. P.; Zeng, S. Y.; Li, D.; Chen, Q. Q.; Luo, D.; Zhang, Z.; Hu, G. Y.; Deng, H. W.; Li, Y. J. Calcitonin gene-related Peptide-mediated depressor effect and inhibiting vascular hypertrophy of rutaecarpine in renovascular hypertensive rats. J. Cardiovasc. Pharmacol. 2007, 50, 654-659.
22. Li, D.; Peng, J.; Xin, H. Y.; Luo, D.; Zhang, Y. S.; Zhou, Z.; Jiang, D. J.; Deng, H. W.; Li, Y. J. Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats. Peptides 2008, 29, 1781-1788.
23. Garry, M. G.; Walton, L. P.; Davis, M. A. Capsaicin-evoked release of immunoreactive calcitonin gene-related peptide from the spinal cord is mediated by nitric oxide but not by cyclic GMP. Brain Res. 2000, 861, 208-219.
24. Zhou, Z. H.; Deng, H. W.; Li, Y. J. Involvement of calcitonin gene-related peptide in the development of tolerance to nitroglycerin in the rat. Eur. J. Pharmacol. 2001, 427, 137-141.
25. Gray, D. W.; Marshall, I. Nitric oxide synthesis inhibitors attenuate calcitonin gene-related peptide endothelium-dependent vasorelaxation in rat aorta. Eur. J. Pharmacol. 1992, 212, 37-42.
26. Gray, D. W.; Marshall, I. Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide. Br. J. Pharmacol. 1992, 107, 691-696.
27. Hu, C. P.; Li, Y. J.; Deng, H. W. The cardioprotective effects of nitroglycerin-induced preconditioning are mediated by calcitonin gene-related peptide. Eur. J. Pharmacol. 1999, 369, 189-194.
28. Underwood, R.; Chiravuri, M.; Lee, H.; Schmitz, T.; Kabcenell, A. K.; Yardley, K.; Huber, B. T. Sequence, purification, and cloning of an intracellular serine protease, quiescent cell proline dipeptidase. J. Biol. Chem. 1999, 274, 34053-34058.
29. Qin, X. P.; Zeng, S. Y.; Tian, H. H.; Deng, S. X.; Ren, J. F.; Zheng, Y. B.; Li, D.; Li, Y. J.; Liao, D. F.; Chen, S. Y. Involvement of prolylcarboxypeptidase in the effect of rutaecarpine on the regression of mesenteric artery hypertrophy in renovascular hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2009, 36, 319-324.
30. Sheen, W. S.; Tsai, I. L.; Teng, C. M.; Ko, F. N.; Chen, I. S. Indolopyridoquinazoline alkaloids with antiplatelet aggregation activity from Zanthoxylum integrifoliolum. Planta Med. 1996, 62, 175-176.
31. Sheu, J. R.; Hung, W. C.; Lee, Y. M.; Yen, M. H. Mechanism of inhibition of platelet aggregation by rutaecarpine, an alkaloid isolated from Evodia rutaecarpa. Eur. J. Pharmacol. 1996, 318, 469-475.
32. Sheu, J. R.; Kan, Y. C.; Hung, W. C.; Su, C. H.; Lin, C. H.; Lee, Y. M.; Yen, M. H. The antiplatelet activity of rutaecarpine, an alkaloid isolated from Evodia rutaecarpa, is mediated through inhibition of phospholipase C. Thromb. Res. 1998, 92, 53-64.
33. Steffel, J.; Luscher, T. F.; Tanner, F. C. Tissue factor in cardiovascular diseases: Molecular mechanisms and clinical implications. Circulation 2006, 113, 722-731.
34. Wenzel, S. E. Arachidonic acid metabolites: Mediators of inflammation in asthma. Pharmacotherapy 1997, 17, 3S-12S. (Pubitemid 27057108)
35. Woo, H. G.; Lee, C. H.; Noh, M. S.; Lee, J. J.; Jung, Y. S.; Baik, E. J.; Moon, C. H.; Lee, S. H. Rutaecarpine, a quinazolinocarboline alkaloid, inhibits prostaglandin production in RAW264.7 macrophages. Planta Med. 2001, 67, 505-509.
36. Choi, Y. H.; Shin, E. M.; Kim, Y. S.; Cai, X. F.; Lee, J. J.; Kim, H. P. Anti-inflammatory principles from the fruits of Evodia rutaecarpa and their cellular action mechanisms. Arch. Pharm. Res. 2006, 29, 293-297.
37. Yu, P. L.; Chao, H. L.; Wang, S. W.; Wang, P. S. Effects of evodiamine and rutaecarpine on the secretion of corticosterone by zona fasciculata- reticularis cells in male rats. J. Cell Biochem. 2009, 108, 469-475.
38. Yarosh, D. B.; Galvin, J. W.; Nay, S. L.; Pena, A. V.; Canning, M. T.; Brown, D. A. Anti-inflammatory activity in skin by biomimetic of Evodia rutaecarpa extract from traditional Chinese medicine. J. Dermatol. Sci. 2006, 42, 13-21.
39. Ko, H. C.; Wang, Y. H.; Liou, K. T.; Chen, C. M.; Chen, C. H.; Wang, W. Y.; Chang, S.; Hou Y. C.; Chen, K. T.; Chen, C. F.; Shen, Y. C. Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells. Eur. J. Pharmacol. 2007, 555, 211-217. (Pubitemid 46048800)
40. Beak, S. M.; Paek, S. H.; Jahng, Y.; Lee Y. S.; Kim, J. A. Inhibition of UVA irradiation-modulated signaling pathways by rutaecarpine, a quinazolinocarboline alkaloid, in human keratinocytes. Eur. J. Pharmacol. 2004, 498, 19-25. (Pubitemid 39208056)
41. Bobik, A.; Kalinina, N. Tumor necrosis factor receptor and ligand superfamily family members TNFRSF14 and LIGHT: New players in human atherogenesis. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1873-1875. (Pubitemid 34219735)
42. Heo, S. K.; Yun, H. J.; Yi, H. S.; Noh, E. K.; Park, S. D. Evodiamine and rutaecarpine inhibit migration by LIGHT via suppression of NADPH oxidase activation. J. Cell Biochem. 2009, 107, 123-133.
43. Kim, S. J.; Lee, S. J.; Lee, S.; Chae, S.; Han, M. D.; Mar, W.; Nam, K. W. Rutaecarpine ameliorates bodyweight gain through the inhibition of orexigenic neuropeptides NPY and AgRP in mice. Biochem. Biophys. Res. Commun. 2009, 389, 437-442.
44. Chen, Z.; Hu, G.; Li, D.; Chen, J.; Li, Y.; Zhou, H.; Xie, Y. Synthesis and vasodilator effects of rutaecarpine analogues which might be involved transient receptor potential vanilloid subfamily, member 1 (TRPV1). Bioorg. Med. Chem. 2009, 17, 2351-2359.
45. Ding, J. S.; Gao, R.; Li, D.; Peng, J.; Ran, L. L.; Li, Y. J. Solid dispersion of rutaecarpine improved its antihypertensive effect in spontaneously hypertensive rats. Biopharm. Drug Dispos. 2008, 29, 495-500.